ArticleFrontiers in oncology2025

Case Report: Zinc deficiency as a modifiable risk factor for enfortumab vedotin-induced cutaneous adverse events.

Aya Nishizawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.